Pain Burden in Post-COVID-19 Syndrome following Mild COVID-19 Infection.
Bileviciute-Ljungar, Indre, Norrefalk, Jan-Rickard, Borg, Kristian · Journal of clinical medicine · 2022 · DOI
Quick Summary
This study looked at 100 people who had mild COVID-19 but developed long-lasting symptoms afterward. Researchers asked about their pain, fatigue, sleep problems, and quality of life. Three-quarters of the participants reported widespread pain in various parts of their body, and many showed signs of fibromyalgia. The study found that pain is a major problem for people with long COVID and needs better treatment.
Why It Matters
Pain is frequently overlooked in post-COVID syndrome despite significantly impacting quality of life and function. This study documents that pain affects the majority of long COVID patients and should be recognized as a core symptom requiring clinical attention, similar to fatigue and post-exertional malaise. For ME/CFS researchers, this highlights the shared pain burden between post-COVID syndrome and ME/CFS, supporting the need for integrated pain management strategies in both conditions.
Observed Findings
75% of participants reported generalized pain, with 50% having clinically estimated generalized pain
40% of participants met suspected fibromyalgia diagnostic criteria (2016 ACR)
Most common pain locations were head/face, chest, lower extremities, and migrating sites
56% of participants were employed full or part time despite symptom burden
Subgroup analyses suggested comorbidities may contribute to pain development
Inferred Conclusions
Pain is a major and prevalent symptom in post-COVID-19 syndrome following even mild initial infection
Post-COVID pain frequently presents as generalized or widespread pain, resembling fibromyalgia patterns
Pain management should be integrated into comprehensive post-COVID syndrome treatment protocols
Pre-existing comorbidities may increase vulnerability to pain in post-COVID syndrome
Remaining Questions
What is the mechanism by which SARS-CoV-2 infection triggers widespread pain in susceptible individuals?
How does pain in post-COVID syndrome differ mechanistically from fibromyalgia or ME/CFS-associated pain?
What This Study Does Not Prove
This study cannot establish whether pain is directly caused by SARS-CoV-2 infection, as it lacks a control group and cannot exclude pre-existing or concurrent conditions. The cross-sectional design means we cannot determine whether pain develops before or after other post-COVID symptoms. The high female representation (82%) limits conclusions about pain prevalence in male patients with post-COVID syndrome.